News & Updates

Tacrolimus appears to be more effective than cyclosporine in improving patient and graft survival after liver transplantation (LT) for primary sclerosing cholangitis (PSC), results of a study have shown.

A retrospective, propensity score-matched analysis from Singapore demonstrates the feasibility of transanal total mesorectal excision with delayed coloanal anastomosis (TaTME-DCAA) as a surgical alternative for non-metastatic low rectal cancer.

The guanylate cyclase C agonist linaclotide helps increase the frequency of bowel movements in children with functional constipation, according to data from a phase III trial.

In advanced nonsmall cell lung cancer (NSCLC) patients with anorexia, treatment with mirtazapine leads to a substantial increase in energy intake despite having no effect on appetite, as shown in a study.

High-flow nasal cannula therapy (HFNT) is effective in reducing the intensity of the sensory and affective components of dyspnoea, independent of oxygen addition, suggests a study.

Oesophageal cancer survivors are more likely to develop late-onset pneumonia during their clinical course, a study suggests.

New drug applications approved by US FDA as of 01-15 January 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

In older patients with resected biliary tract cancer, adjuvant chemotherapy does not appear to yield significant survival gains when compared with observation, according to a study.